Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model

Mutations in the VAV1 guanine nucleotide exchange factor 1 have been recently found in peripheral T cell lymphoma and nonsmall-cell lung cancer (NSCLC). To understand their pathogenic potential, we generated a gene-edited mouse model that expresses a VAV1 mutant protein that recapitulates the signal...

Full description

Bibliographic Details
Authors: Robles-Valero, Javier, Fernández-Nevado, Lucía, Cuadrado, Myriam, Lorenzo-Martín, L. Francisco, Fernández-Pisonero, Isabel, Abad, Antonio, Redín, Esther, Montuenga, Luis, Martín-Zanca, Dionisio, Bigas Salvans, Anna, Mallo, Moises, Dosil, Mercedes, Bustelo, Xose R.
Format: article
Status:Published version
Publication Date:2022
Country:España
Institution:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10230/55662
Online Access:http://hdl.handle.net/10230/55662
http://dx.doi.org/10.1002/1878-0261.13295
Access Level:Open access
Keyword:RAC1
TP53
Angioimmunoblastic T cell lymphoma
Follicular helper T cells
Nonsmall-cell lung cancer
Peripheral T cell lymphoma
Description
Summary:Mutations in the VAV1 guanine nucleotide exchange factor 1 have been recently found in peripheral T cell lymphoma and nonsmall-cell lung cancer (NSCLC). To understand their pathogenic potential, we generated a gene-edited mouse model that expresses a VAV1 mutant protein that recapitulates the signalling alterations present in the VAV1 mutant subclass most frequently found in tumours. We could not detect any overt tumourigenic process in those mice. However, the concurrent elimination of the Trp53 tumour suppressor gene in them drives T cell lymphomagenesis. This process represents an exacerbation of the normal functions that wild-type VAV1 plays in follicular helper T cells. We also found that, in combination with the Kras oncogene, the VAV1 mutant version favours progression of NSCLC. These data indicate that VAV1 mutations play critical, although highly cell-type-specific, roles in tumourigenesis. They also indicate that such functions are contingent on the mutational landscape of the tumours involved.